Related Experiment Video

Updated: Jun 18, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F)

Lequn Zhao1, Yue Ma, Joachim Seemann

  • 1Department of Cell Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, U.S.A.

The Biochemical Journal
|November 26, 2009
PubMed

Insights

The V617F mutation in Janus tyrosine kinase 2 (JAK2) enhances its activity by lowering substrate binding affinity (Km), particularly requiring the FERM domain. This contrasts with the FERM domain's inhibitory role in wild-type JAK2.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Janus tyrosine kinase 2 (JAK2) is crucial for cytokine receptor signaling.
  • A gain-of-function JAK2 mutation (V617F) is linked to myeloproliferative neoplasms.
  • The mechanism of JAK2 V617F hyperactivation remains unclear.

Purpose of the Study:

  • To elucidate the biochemical mechanism behind JAK2 V617F hyperactivation.
  • To investigate the role of the JAK2 FERM domain in regulating kinase activity.

Main Methods:

  • Enzyme kinetics assays (Vmax, Km) were performed on wild-type JAK2 and JAK2(V617F).
  • Site-directed mutagenesis and domain deletion (FERM domain) were employed.
  • Kinase activity assays were conducted on wild-type JAK2 and mutant variants.

Main Results:

  • The V617F mutation decreased the Km for JAK2 substrates but did not significantly alter Vmax.
  • The FERM domain was essential for the V617F-mediated decrease in Km.
  • The FERM domain inhibited wild-type JAK2 activity, and its deletion or mutation increased basal kinase activity.

Conclusions:

  • The V617F mutation hyperactivates JAK2 by reducing substrate affinity, a process dependent on the FERM domain.
  • The JAK2 FERM domain plays distinct regulatory roles, inhibiting wild-type JAK2 while being necessary for V617F hyperactivation.
  • These findings provide a biochemical basis for JAK2 V617F-driven myeloproliferative neoplasms and highlight novel FERM domain regulation.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...